The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for H Arnhof


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands.EBI
Boehringer Ingelheim Rcv
Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors.EBI
Vanderbilt University School of Medicine
Discovery of BI 7446: A Potent Cyclic Dinucleotide STING Agonist with Broad-Spectrum Variant Activity for the Treatment of Cancer.EBI
Boehringer Ingelheim Pharma
Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRASEBI
Boehringer Ingelheim Rcv
One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS.EBI
Boehringer Ingelheim Rcv
Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding Functions.EBI
Boehringer Ingelheim Rcv
Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor EBI
Boehringer Ingelheim Rcv
Bispyrimidines as potent histamine H(4) receptor ligands: delineation of structure-activity relationships and detailed H(4) receptor binding mode.EBI
Boehringer Ingelheim Rcv
PCSK9 inhibitors and methods of use thereofBDB
Astrazeneca
Triazolopyrimidine compounds and uses thereofBDB
Novartis